Health Insurance Innovations, Inc. (NASDAQ:HIIQ) CEO Bruce Telkamp sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $27.76, for a total value of $416,400.00. Following the completion of the sale, the chief executive officer now owns 45,801 shares of the company’s stock, valued at $1,271,435.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Bruce Telkamp also recently made the following trade(s):

  • On Wednesday, August 2nd, Bruce Telkamp sold 15,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $26.27, for a total value of $394,050.00.
  • On Monday, July 24th, Bruce Telkamp sold 15,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $27.76, for a total value of $416,400.00.
  • On Wednesday, July 26th, Bruce Telkamp sold 30,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $28.30, for a total value of $849,000.00.
  • On Monday, July 17th, Bruce Telkamp sold 15,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $26.50, for a total value of $397,500.00.
  • On Tuesday, July 18th, Bruce Telkamp sold 30,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $26.68, for a total value of $800,400.00.
  • On Friday, May 26th, Bruce Telkamp sold 3,901 shares of Health Insurance Innovations stock. The stock was sold at an average price of $22.60, for a total value of $88,162.60.
  • On Friday, May 12th, Bruce Telkamp sold 18,745 shares of Health Insurance Innovations stock. The stock was sold at an average price of $21.94, for a total value of $411,265.30.
  • On Wednesday, May 10th, Bruce Telkamp sold 24,179 shares of Health Insurance Innovations stock. The stock was sold at an average price of $20.25, for a total value of $489,624.75.

Shares of Health Insurance Innovations, Inc. (NASDAQ HIIQ) opened at 31.70 on Friday. The company has a market capitalization of $366.14 million, a PE ratio of 25.65 and a beta of 0.68. Health Insurance Innovations, Inc. has a 52-week low of $3.90 and a 52-week high of $32.95. The stock’s 50 day moving average price is $25.25 and its 200-day moving average price is $20.08.

Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.13. The business had revenue of $61.80 million during the quarter, compared to analysts’ expectations of $53.69 million. Health Insurance Innovations had a return on equity of 23.92% and a net margin of 5.56%. The firm’s revenue was up 38.9% on a year-over-year basis. On average, analysts expect that Health Insurance Innovations, Inc. will post $1.48 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/05/health-insurance-innovations-inc-nasdaqhiiq-ceo-sells-416400-00-in-stock.html.

A number of brokerages have recently commented on HIIQ. UBS AG upgraded Health Insurance Innovations to an “outperform” rating in a report on Thursday, May 4th. Zacks Investment Research upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $33.00 price target for the company in a report on Friday. Craig Hallum reiterated a “buy” rating and set a $38.00 price target (up from $28.00) on shares of Health Insurance Innovations in a report on Thursday. Canaccord Genuity reiterated a “buy” rating and set a $39.00 price target (up from $30.00) on shares of Health Insurance Innovations in a report on Friday. Finally, TheStreet upgraded Health Insurance Innovations from a “c” rating to a “b-” rating in a report on Monday, May 22nd. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Health Insurance Innovations has a consensus rating of “Buy” and an average price target of $30.83.

Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its stake in Health Insurance Innovations by 1,031.7% in the fourth quarter. Renaissance Technologies LLC now owns 213,900 shares of the financial services provider’s stock valued at $3,818,000 after buying an additional 195,000 shares during the last quarter. Bank of Montreal Can purchased a new stake in Health Insurance Innovations during the first quarter valued at $118,000. Navellier & Associates Inc boosted its stake in Health Insurance Innovations by 187.5% in the first quarter. Navellier & Associates Inc now owns 70,943 shares of the financial services provider’s stock valued at $1,135,000 after buying an additional 46,265 shares during the last quarter. Northpointe Capital LLC purchased a new stake in Health Insurance Innovations during the first quarter valued at $2,485,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in Health Insurance Innovations during the first quarter valued at $6,383,000. 71.94% of the stock is owned by institutional investors and hedge funds.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.